# Urinary Transglutaminase 2 as a Biomarker for Kidney Allograft Fibrosis

> **NCT03487861** · — · UNKNOWN · sponsor: **Asan Medical Center** · enrollment: 1000 (estimated)

## Conditions studied

- Kidney Allograft Fibrosis
- Kidney Transplant Failure and Rejection

## Interventions

- **DIAGNOSTIC_TEST:** observational(urinary biomarker for kidney allograft fibrosis)

## Key facts

- **NCT ID:** NCT03487861
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08-29
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2018-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03487861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03487861, "Urinary Transglutaminase 2 as a Biomarker for Kidney Allograft Fibrosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03487861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*